clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Hyperemesis Gravidarum D006939 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Mastoiditis D008417 2 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Scrub Typhus D012612 3 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Shaulov A et al. Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. 2017 Am. J. Hematol. pmid:27804150
Gaur S et al. Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection. 2004 Am. J. Hematol. pmid:15307101
Rostami N et al. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. 2008 Am. J. Hematol. pmid:18183613
Ghosh N et al. Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma. 2014 Am. J. Hematol. pmid:24723438
Gay F et al. Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma. 2010 Am. J. Hematol. pmid:20645430
Mirabile A et al. MALT lymphoma and Kaposi sarcoma in an HIV-negative patient. 2010 Am. J. Hematol. pmid:20721890
Steinman MA and Steinman TI Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis. 1996 Am. J. Kidney Dis. pmid:8546130
Wang YL et al. Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients. 2001 Am. J. Kidney Dis. pmid:11431188
Mendu ML and Waikar SS Drug-drug interactions and acute kidney injury: caveat prescriptor. 2014 Am. J. Kidney Dis. pmid:24820318
Okada S et al. Angiocentric immunoproliferative lesions of the lung associated with diffuse renal involvement. 2002 Am. J. Kidney Dis. pmid:11877592
Mak SK et al. Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure. 2002 Am. J. Kidney Dis. pmid:12200810
Sekkarie MA Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin. 1997 Am. J. Kidney Dis. pmid:9292575
Keenan N et al. Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis. 2005 Am. J. Kidney Dis. pmid:15861339
Santos MA et al. Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection. 2017 Am. J. Med. pmid:27984010
Curtis LH et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. 2003 Am. J. Med. pmid:12586234
Nayyar E and Taimur S Sporotrichoid lesions: an age-old conundrum. 2015 Am. J. Med. pmid:26021809
Jaber BL et al. The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin. 2006 Am. J. Med. pmid:16564762
Cicconi V et al. Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. 2001 Am. J. Med. pmid:11501549
Siddiqui J Immunomodulatory effects of macrolides: implications for practicing clinicians. 2004 Am. J. Med. pmid:15586561
Tamaoki J et al. Clinical implications of the immunomodulatory effects of macrolides. 2004 Am. J. Med. pmid:15586558
Abisheganaden JA et al. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial. 2000 Am. J. Med. pmid:10781777
Gotfried MH Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program. 2001 Am. J. Med. pmid:11755440
Sherman PM Appropriate strategies for testing and treating Helicobacter pylori in children: when and how? 2004 Am. J. Med. pmid:15478850
Sokol W Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. 2001 Am. J. Med. pmid:11755439
Pfaller MA et al. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. 2001 Am. J. Med. pmid:11755437
Lee KL et al. QT prolongation and Torsades de Pointes associated with clarithromycin. 1998 Am. J. Med. pmid:9576415
Hunt RH Eradication of Helicobacter pylori infection. 1996 Am. J. Med. pmid:8644782
Stasi R et al. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. 2005 Am. J. Med. pmid:15808140
Gokturk HS et al. Does long-term aspirin use have any effect on Helicobacter pylori eradication? 2011 Am. J. Med. Sci. pmid:21642817
Brener ZZ et al. Rhabdomyolysis following clarithromycin monotherapy. 2009 Am. J. Med. Sci. pmid:19474653
Songür Y et al. Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. 2009 Am. J. Med. Sci. pmid:19474657
Demir M et al. Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. 2009 Am. J. Med. Sci. pmid:19884816
Butt AA Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. 1998 Am. J. Med. Sci. pmid:9427575
Baciewicz AM et al. Update on rifampin and rifabutin drug interactions. 2008 Am. J. Med. Sci. pmid:18277121
Gascón A et al. Catheter salvage in a patient on hemodialysis with a catheter-related bacteremia by Pseudomonas aeruginosa. Usefulness of clarithromycin. 2000 Nov-Dec Am. J. Nephrol. pmid:11146320
Witt A et al. Placental passage of clarithromycin surpasses other macrolide antibiotics. 2003 Am. J. Obstet. Gynecol. pmid:12634663
Lin KJ et al. Safety of macrolides during pregnancy. 2013 Am. J. Obstet. Gynecol. pmid:23254249
Kuehne JJ et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. 2004 Am. J. Ophthalmol. pmid:15488779
Helm CJ et al. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. 1993 Am. J. Ophthalmol. pmid:8250072
Chandra NS et al. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. 2001 Am. J. Ophthalmol. pmid:11730644
Feldman M et al. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. 1999 Am. J. Physiol. pmid:10600812
Kaneko Y et al. Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12818892
Shinkai M et al. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16085674
Chmura K et al. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. 2008 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18487355
Tanabe T et al. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21642590
Abe S et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. 2000 Am. J. Respir. Cell Mol. Biol. pmid:10615065
Oberley-Deegan RE et al. The antioxidant mimetic, MnTE-2-PyP, reduces intracellular growth of Mycobacterium abscessus. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19097985
Yamasawa H et al. Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. 2004 Am. J. Respir. Cell Mol. Biol. pmid:14551160
Stout JE and Floto RA Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. 2012 Am. J. Respir. Crit. Care Med. pmid:23118083
Pasipanodya JG and Gumbo T Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions. 2013 Am. J. Respir. Crit. Care Med. pmid:23457368